Registered entities
Bioxcel Therapeutics, Inc.
Reg. No. 1720893United States
Bioxcel Therapeutics, Inc
Reg. No. 32093828443United States
Bioxcel Corporation
Reg. No. 202612128United States
Innovation
28 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 15,725 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 15 |
| 2022 | 14 |
| 2023 | 14 |
| 2024 | 14 |
| 2025 | 12 |
| 2026 | 2 |
Social engagement
Social engagement: 10.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Recent activity
30 Jun 2026
Recognition
23 Apr 2026
Event
IGALMI® at-home launch strategy and commercial preparation
22 Apr 2026
Event
IGALMI® virtual event